The aim is to reach out to the people of Delhi and encourage them to donate plasma. The need of the hour is to come forward and help in whichever way possible.
@ArvindKejriwal @CMODelhi @RedFMIndia @rjraunac
Show this thread
Plasma therapy as a cure to Covid-19 has kindled a ray of hope for those affected with the virus. In an endeavour to reach out to masses & educate and inform them about the availability of plasma, we are launching our new campaign, 'Dilli Deke Dekho'
@CMODelhi @ArvindKejriwalpic.twitter.com/jfIjqDwBCu
-
-
-
We are hopeful that in some way this will help bridge the gap between donors and patients. Its a tough battle but we cannot stop till its over. Stay safe and do your bit.
@rjraunac@RedFMIndia@CMODelhi@ArvindKejriwalShow this thread
End of conversation
New conversation -
-
-
Great initiative ma'am. Keep up the good work
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
A good endeavour
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
Thanks...Great initiative....God bless you all
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
Great initiative team Red FM
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
मुझे जो भी Follow करेगा मैं उसे 10 Second के अंदर Follow Back करता हूँ !! अगर नहीं किया तो मुझे Unfollow कर लेना ।
@RajuRanjanJiThanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
There is only very low-certainty evidence for safety and effectiveness of plasma therapy for COVID-19 (Cochrane study). As this therapy is still investigational, undue hype is just to score browny points by politicians.pic.twitter.com/R0ckW8bv43
-
I will take that low chance if it Saves someone and I am sure you will too if it was your loved one who was in need of someone who believed in taking that chance
- 1 more reply
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.